Literature DB >> 6871851

Quantitative selectivity of contact-mediated intercellular communication in a metastatic mouse mammary tumor line.

B E Miller, L D Roi, L M Howard, F R Miller.   

Abstract

We have examined contact-mediated intercellular communication by measuring the transfer of thioguanine sensitivity to a hypoxanthine phosphoribosyltransferase (EC 2.4.2.8)-negative clone (66cl-4) selected from one subline isolated previously from a spontaneously arising mammary tumor of a BALB/cfC3H mouse. We tested other sublines from the same tumor and unrelated cell types for their ability to serve as 6-thioguanine nucleotide donors to 66cl-4 cells. The degree of communication, measured by the number of donor cells required to reduce the number of thioguanine-resistant colonies, varied with the donor cell type. The 66cl-4 line communicated with the parent cell line from which the thioguanine-resistant cell was selected and with other sublines from the parent tumor, with some unrelated tumor cells, and with some nonneoplastic cells (3T3, hamster kidney and lung fibroblasts, and mouse mammary epithelial cells). There was a quantitative difference in the amount of communication which took place with the various cells tested, but no pattern of difference could be discerned. Line 66cl-4 did not preferentially communicate with cells of epithelial versus fibroblast morphology, nor with tumor versus nontumor cells. The 66cl-4 cells retained the ability of their parent line to form metastatic tumors when injected s.c. into BALB/c mice. A quantitative selectivity of communication is thus expressed in these malignant metastatic cells, but it is apparently unrelated to either the morphological or malignant phenotype of the donor. Contact-mediated communication between tumor subpopulations may differentially affect growth and drug sensitivity within a tumor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871851

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.

Authors:  A M Tester; N Ruangpanit; R L Anderson; E W Thompson
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents.

Authors:  B E Miller; L Delmonico; K Vistisen; F R Miller
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

3.  Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.

Authors:  Mikayel Mkrtichyan; Anahit Ghochikyan; Hayk Davtyan; Nina Movsesyan; Dmitry Loukinov; Victor Lobanenkov; David H Cribbs; Amanda K Laust; Edward L Nelson; Michael G Agadjanyan
Journal:  Cell Immunol       Date:  2011-05-12       Impact factor: 4.868

4.  Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils.

Authors:  Nathaniel Robichaud; Brian E Hsu; Roman Istomine; Fernando Alvarez; Julianna Blagih; Eric H Ma; Sebastian V Morales; David L Dai; Glenn Li; Margarita Souleimanova; Qianyu Guo; Sonia V Del Rincon; Wilson H Miller; Santiago Ramón Y Cajal; Morag Park; Russell G Jones; Ciriaco A Piccirillo; Peter M Siegel; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

5.  SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.

Authors:  Chu-An Wang; Paul Jedlicka; Aaron N Patrick; Douglas S Micalizzi; Kimberly C Lemmer; Erin Deitsch; Matias Casás-Selves; J Chuck Harrell; Heide L Ford
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

6.  A novel orthotopic model of breast cancer metastasis to bone.

Authors:  M Lelekakis; J M Moseley; T J Martin; D Hards; E Williams; P Ho; D Lowen; J Javni; F R Miller; J Slavin; R L Anderson
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

7.  In vitro chemosensitivity test of human brain tumors using a three-dimensional organ culture with a collagen gel matrix.

Authors:  K Yuki; T Uozumi; Y Kodama; K Kurisu; T Mikami
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Evaluation of the probability of spontaneous transfer of drug resistance between cells in culture.

Authors:  C K Luk; I F Tannock
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

9.  A murine model of bone marrow micrometastasis in breast cancer.

Authors:  Barbara O'Kane Murphy; Shantaram Joshi; Anne Kessinger; Elizabeth Reed; J Graham Sharp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines.

Authors:  B E Miller; F R Miller; D J Wilburn; G H Heppner
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.